Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.68 USD | +0.54% |
|
+2.49% | +2.13% |
07-02 | Tranche Update on Nomura Research Institute, Ltd.'s Equity Buyback Plan announced on April 25, 2024. | CI |
04-25 | Nomura Research Institute’s Attributable Profit Up 4.8% in Fiscal 2024 | MT |
Strengths
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 30.05 and 27.02 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.6 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.13% | 16.94B | - | ||
-7.38% | 204B | A- | ||
+10.15% | 181B | B+ | ||
+13.61% | 171B | B- | ||
+5.52% | 101B | A- | ||
+44.54% | 89.81B | C- | ||
+13.22% | 85.57B | A- | ||
+11.87% | 85.54B | A | ||
+7.06% | 50.83B | A- | ||
-31.55% | 45.61B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4307 Stock
- NRILY Stock
- Ratings Nomura Research Institute, Ltd.